Clinical Trials News

Medindia's Press Release’ section provides the latest press release on Clinical Trials from across the world for the global audience. This page links to 3050 Clinical Trials press releases.

GT Biopharma Announces Preliminary Clinical Results From Interim Review of Phase 1/2 Clinical Trial of OXS-1550, its Bi-Specific Antibody Drug Conjugate

LOS ANGELES , June 11, 2018 /PRNewswire/ -- Clinical benefit observed in more than 50% of patients that met evaluation criteria Efficacy signal most pronounced in relapse...

China Biologic Receives CFDA Clinical Trial Approval for Human Fibrin Sealant

BEIJING , June 11, 2018 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharm...

Global Pharma Clinical Trial Patient Recruitment & Monitoring IT Solutions, Forecast to 2020

LONDON , June 7, 2018 /PRNewswire/ -- Wearables and Mobile Technologies Growth Opportunities in Digital Transformation Journey of Clinical Trials Download the full report: https:www...

Merck KGaA, Darmstadt, Germany Presents Updated Clinical Results for Bifunctional Immunotherapy M7824 at ASCO 2018

DARMSTADT, Germany , June 4, 2018 /PRNewswire/ -- ASCO Abstract # M7824 (TGF-ß trap/anti-PD-L1): 3007, 9017, 2566, TPS3130; Tepotinib (c-Met kinase inhibitor): 9082, 9016; ...

Merck Presents Updated Clinical Results for Bifunctional Immunotherapy M7824 at ASCO 2018

DARMSTADT, Germany , June 4, 2018 /PRNewswire/ -- ASCO Abstract # M7824 (TGF-ß trap/anti-PD-L1): 3007, 9017, 2566, TPS3130; Tepotinib (c-Met kinase inhibitor): 9082, 9016; M...

Cantex Pharmaceuticals, Inc. Announces That Clinical Trial Data For CX-01 In Refractory Acute Myeloid Leukemia And Myelodysplastic Syndrome Will Be Presented At The 2018 ASCO Annual Meeting

WESTON, Fla. , June 4, 2018 /PRNewswire/ -- Cantex Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing proprietary pharmaceuticals for the treatment of cancer...

Forty Seven, Inc. Announces Proof-of-Concept Data from Two Clinical Trials of 5F9 In Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphoma

-- 5F9 Safe and Well-Tolerated Using Proprietary Priming and Maintenance Dosing Strategy -- MENLO PARK, Calif. , June 3, 2018 /PRNewswire/ -- Forty Seven, Inc., a clinical-stage, i...

Menarini Ricerche to Present the Study Design of CD205-Shuttle, a First-in-human Trial of MEN1309/OBT076, at the ASCO Annual Meeting 2018

POMEZIA, Italy , June 1, 2018 /PRNewswire/ -- Menarini Ricerche (Menarini Group) will present at ASCO Annual Meeting 2018 the study design of CD205-Shuttle, a multicenter first-in-h...

Xynomic Pharma Completes Series B Crossover Financing, Starts Four Pivotal Trials in Renal Cell Carcinoma (RCC) and Lymphoma, and Opens a R&D Center

DOVER, Del. and SHANGHAI , June 1, 2018 /PRNewswire/ -- Xynomic Pharma, a clinical stage US-China oncology drug development company, today announced that it has completed Series B Cro...

NW Bio To Discuss Interim Phase 3 Trial Data In Industry Theater Session During ASCO

BETHESDA, Md. , May 31, 2018 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor ...

Advertisement

Clinical Trials News »

Drug Impairs Cancer Cell Growth and Survival

Drug Impairs Cancer Cell Growth and Survival

Pre-clinical results for IACS-10759 drug lead to Phase I clinical trials in acute myeloid leukemia and solid tumors, revealed two papers published in Nature Medicine. ...

Protein Inhibitor Drug Benefits AML Patients

Protein Inhibitor Drug Benefits AML Patients

In a study of patients with acute myeloid leukemia (AML) with relapsed or refractory disease, ivosidenib, an experimental drug known to inhibit a protein often mutated in several cancers was found to be safe, resulting in durable remissions. ...

First Human Trials Of Alzheimer's Drug

First Human Trials Of Alzheimer's Drug

UK is set to launch the first human trials of ground-breaking drug shown to repair DNA damage that contributes to Alzheimer's disease, reported sources. The study, also being launched this week in hospitals in France and Spain, will see the ...

 Prescribed Medication Along With PCI Better Treatment for Heart Disease Patients

Prescribed Medication Along With PCI Better Treatment for Heart Disease Patients

People with common heart disease are most often treated with just medication, however a non-surgical procedure, called percutaneous coronary intervention (PCI), along with prescribed medication is best recommended for such patients, suggest an ...

Ovarian Cancer Drug Rucaparib Can Treat Pancreatic Cancer Patients With BRCA Mutation

Ovarian Cancer Drug Rucaparib Can Treat Pancreatic Cancer Patients With BRCA Mutation

Patients with aggressive pancreatic cancer with BRCA1 and BRCA2 mutations who have few or no other treatment options can benefit from rucaparib drug. In a previous targeted therapy rucaparib has shown its power in fighting ovarian cancer in women ...

More Clinical Trials News

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store